Volume 47, Issue 6, Pages (September 2012)

Slides:



Advertisements
Similar presentations
Volume 50, Issue 6, Pages (June 2013)
Advertisements

Volume 55, Issue 1, Pages (July 2014)
Volume 13, Issue 3, Pages (October 2015)
Volume 57, Issue 3, Pages (February 2015)
Volume 54, Issue 1, Pages (April 2014)
Volume 44, Issue 4, Pages (November 2011)
Yu-Hsin Chiu, Jennifer Y. Lee, Lewis C. Cantley  Molecular Cell 
Volume 65, Issue 2, Pages (January 2017)
NRF2 Is a Major Target of ARF in p53-Independent Tumor Suppression
Richard C. Centore, Stephanie A. Yazinski, Alice Tse, Lee Zou 
Volume 65, Issue 5, Pages e5 (March 2017)
Volume 17, Issue 18, Pages (September 2007)
Volume 16, Issue 6, Pages (June 2015)
Volume 19, Issue 6, Pages (September 2005)
Volume 45, Issue 5, Pages (March 2012)
Volume 68, Issue 2, Pages e6 (October 2017)
Enxuan Jing, Stephane Gesta, C. Ronald Kahn  Cell Metabolism 
Volume 22, Issue 7, Pages (February 2018)
Robert L.S Perry, Maura H Parker, Michael A Rudnicki  Molecular Cell 
Volume 18, Issue 23, Pages (December 2008)
Coupling of Homologous Recombination and the Checkpoint by ATR
Volume 41, Issue 2, Pages (January 2011)
Glucose-Induced β-Catenin Acetylation Enhances Wnt Signaling in Cancer
Volume 55, Issue 4, Pages (August 2014)
Calnexin Controls the STAT3-Mediated Transcriptional Response to EGF
Yph1p, an ORC-Interacting Protein
Jungmook Lyu, Vicky Yamamoto, Wange Lu  Developmental Cell 
14-3-3σ Regulates Keratinocyte Proliferation and Differentiation by Modulating Yap1 Cellular Localization  Sumitha A.T. Sambandam, Ramesh B. Kasetti,
FOXO3a Is Activated in Response to Hypoxic Stress and Inhibits HIF1-Induced Apoptosis via Regulation of CITED2  Walbert J. Bakker, Isaac S. Harris, Tak.
Volume 45, Issue 6, Pages (March 2012)
Volume 16, Issue 6, Pages (December 2012)
Volume 26, Issue 6, Pages (September 2013)
HDAC5, a Key Component in Temporal Regulation of p53-Mediated Transactivation in Response to Genotoxic Stress  Nirmalya Sen, Rajni Kumari, Manika Indrajit.
Volume 70, Issue 2, Pages e6 (April 2018)
TRF2 Protects Human Telomeres from End-to-End Fusions
Volume 69, Issue 3, Pages e5 (February 2018)
Proteolytic Cleavage of Opa1 Stimulates Mitochondrial Inner Membrane Fusion and Couples Fusion to Oxidative Phosphorylation  Prashant Mishra, Valerio.
Volume 48, Issue 4, Pages (November 2012)
Volume 56, Issue 5, Pages (December 2014)
Purification of Human Telomerase Complexes Identifies Factors Involved in Telomerase Biogenesis and Telomere Length Regulation  Dragony Fu, Kathleen Collins 
Septins Regulate Actin Organization and Cell-Cycle Arrest through Nuclear Accumulation of NCK Mediated by SOCS7  Brandon E. Kremer, Laura A. Adang, Ian.
Volume 43, Issue 1, Pages (July 2011)
Volume 42, Issue 2, Pages e3 (July 2017)
A Critical Role for Noncoding 5S rRNA in Regulating Mdmx Stability
Honglin Li, Hong Zhu, Chi-jie Xu, Junying Yuan  Cell 
Yi Tang, Jianyuan Luo, Wenzhu Zhang, Wei Gu  Molecular Cell 
Volume 42, Issue 5, Pages (June 2011)
Volume 19, Issue 6, Pages (September 2005)
Autoantigen La Promotes Efficient RNAi, Antiviral Response, and Transposon Silencing by Facilitating Multiple-Turnover RISC Catalysis  Ying Liu, Huiling.
Ribosome Collision Is Critical for Quality Control during No-Go Decay
A Dynamic Molecular Link between the Telomere Length Regulator TRF1 and the Chromosome End Protector TRF2  Benjamin R. Houghtaling, Leanora Cuttonaro,
ULK1 Phosphorylates and Regulates Mineralocorticoid Receptor
Mitochondrial p32 Is a Critical Mediator of ARF-Induced Apoptosis
Mst1 Is an Interacting Protein that Mediates PHLPPs' Induced Apoptosis
STIL Microcephaly Mutations Interfere with APC/C-Mediated Degradation and Cause Centriole Amplification  Christian Arquint, Erich A. Nigg  Current Biology 
Volume 54, Issue 6, Pages (June 2014)
PUMA, a Novel Proapoptotic Gene, Is Induced by p53
Yap1 Phosphorylation by c-Abl Is a Critical Step in Selective Activation of Proapoptotic Genes in Response to DNA Damage  Dan Levy, Yaarit Adamovich,
Volume 125, Issue 4, Pages (May 2006)
Volume 45, Issue 3, Pages (February 2012)
Hua Gao, Yue Sun, Yalan Wu, Bing Luan, Yaya Wang, Bin Qu, Gang Pei 
Feng Xu, Qiongyi Zhang, Kangling Zhang, Wei Xie, Michael Grunstein 
Volume 43, Issue 5, Pages (September 2011)
Volume 60, Issue 2, Pages (October 2015)
Volume 55, Issue 1, Pages (July 2014)
Volume 18, Issue 6, Pages (June 2005)
Volume 65, Issue 5, Pages e4 (March 2017)
c-IAP1 Cooperates with Myc by Acting as a Ubiquitin Ligase for Mad1
Volume 31, Issue 5, Pages (September 2008)
Volume 21, Issue 4, Pages (October 2017)
Presentation transcript:

Volume 47, Issue 6, Pages 839-850 (September 2012) Mitochondrial Localization of Telomeric Protein TIN2 Links Telomere Regulation to Metabolic Control  Liuh-Yow Chen, Yi Zhang, Qinfen Zhang, Hongzhi Li, Zhenhua Luo, Hezhi Fang, Sok Ho Kim, Li Qin, Patricia Yotnda, Jianming Xu, Benjamin P. Tu, Yidong Bai, Zhou Songyang  Molecular Cell  Volume 47, Issue 6, Pages 839-850 (September 2012) DOI: 10.1016/j.molcel.2012.07.002 Copyright © 2012 Elsevier Inc. Terms and Conditions

Figure 1 TIN2 Localizes to Both the Nucleus and Mitochondria (A) HTC75 cells were immunostained with anti-TIN2 antibodies. Telomeres and mitochondria were marked with anti-TRF2 and ATP5A1 antibodies, and nuclei stained with DAPI. (B and C) Immunogold analysis in HT1080 (B) and U2OS (C) cells expressing control or TIN2-targeting shRNA. Cells were probed with anti-TIN2 antibodies. Arrows indicate gold particles. Scale bars represent 200 nm. (D) Immunostaining of HTC75 cells expressing C-terminally tagged TIN2 proteins. TIN2-flag was stained with anti-flag antibodies. (E) HTC75 cells expressing flag-tagged full-length (TIN2-flag) or mutant TIN2 (TIN2-Δ18-flag) were fractionated by differential centrifugation. Whole-cell extract (WCE) and cellular fractions (nuclear P1, cytoplasmic S1, soluble cytoplasmic/light membrane S2, and heavy membrane P2) were analyzed. ORC2, tubulin, and ATP5A1 were used as nuclear, cytoplasmic, and mitochondrial markers. (F) P2 fractions from (E) were digested with proteinase K in the presence or absence of detergent before western analysis. See also Figure S1. Molecular Cell 2012 47, 839-850DOI: (10.1016/j.molcel.2012.07.002) Copyright © 2012 Elsevier Inc. Terms and Conditions

Figure 2 TIN2 N Terminus Contains Mitochondrial Targeting Signals (A–C) Immunostaining studies were performed in HTC75 cells expressing GFP-tagged wild-type and N-terminal truncation mutants of TIN2 (A), GFP proteins tagged with TIN2 N-terminal fragments (B), or GFP-tagged wild-type and point mutants of TIN2 (C). Anti-TOM20 or ATP5A1 antibodies were used to mark the mitochondria. Molecular Cell 2012 47, 839-850DOI: (10.1016/j.molcel.2012.07.002) Copyright © 2012 Elsevier Inc. Terms and Conditions

Figure 3 TIN2 Is Proteolytically Processed in the Mitochondria (A) Induction of TIN2 expression in HT1080 cells coexpressing TIN2 shRNA (shTIN2) and doxycycline (Dox)-inducible SFB-tagged wild-type TIN2. Cells expressing shRNA sequences against GFP served as control. (B) Whole cell extracts and mitochondrial fractions from cells in (A) were western blotted following doxycycline induction (48 hr). (C) Whole cell extract and mitochondria fractions from U2OS cells expressing control or TIN2 shRNA were western blotted. (D) HTC75 cells expressing TIN2-Δ18-flag (indicated by circle) were immunoprecipitated with anti-flag antibodies. Arrows indicate TIN2 processed forms that were excised for sequencing. (E) Sequence alignment of TIN2. Arrows indicate human TIN2 processing sites. (F) Western analysis of HEK293 cells transiently expressing flag-tagged wild-type and N-terminal deletion mutants of TIN2. (G) Immunostaining of GFP proteins tagged with the N terminus of zebrafish (aa 1–225) or mouse (aa 1–90) TIN2 in HTC75 cells. See also Table S1. Molecular Cell 2012 47, 839-850DOI: (10.1016/j.molcel.2012.07.002) Copyright © 2012 Elsevier Inc. Terms and Conditions

Figure 4 The N Terminus of TIN2 Mediates TIN2-TPP1 Interaction (A) Wild-type (Wild) and mutant TIN2-GFP proteins were transiently expressed with or without flag-TPP1 in HEK293 cells, immunoprecipitated (IP) with anti-flag antibodies, and western blotted as indicated. Arrow indicates a nonspecific band. (B) Similar analysis of flag-tagged wild-type (Wild) and point mutants of TIN2 proteins in HEK293 cells transiently coexpressing TPP1-V5. (C) Analysis of cells coexpressing TRF1-V5 with flag-tagged wild-type (Wild) or mutant TIN2 proteins. Molecular Cell 2012 47, 839-850DOI: (10.1016/j.molcel.2012.07.002) Copyright © 2012 Elsevier Inc. Terms and Conditions

Figure 5 TPP1 Inhibits TIN2 Mitochondrial Localization and Processing (A) HTC75 cells expressing GFP-tagged wild-type TIN2 or TIN2-F37D/L38E alone or with TPP1-flag were analyzed. Anti-cytochrome c antibodies were used to stain the mitochondria. (B) Percentages of cells with mitochondrial TIN2 signals from (A) were graphed (n ≥ 100). (C) Whole cell extract and mitochondria fractions from cells expressing flag-tagged wild-type (Wild) and mutant TIN2 were western blotted. (D) Western analysis of HEK293 cells transiently coexpressing TPP1-V5 with flag-tagged wild-type (Wild) or mutant TIN2. Molecular Cell 2012 47, 839-850DOI: (10.1016/j.molcel.2012.07.002) Copyright © 2012 Elsevier Inc. Terms and Conditions

Figure 6 TIN2 Expression Regulates Mitochondrial Morphology (A) HTC75 cells stably expressing GFP-tagged wild-type and mutant TIN2 proteins were immunostained with anti-cytochrome C antibodies. (B) Quantification of data from (A) (n ≥ 300). Molecular Cell 2012 47, 839-850DOI: (10.1016/j.molcel.2012.07.002) Copyright © 2012 Elsevier Inc. Terms and Conditions

Figure 7 TIN2 Modulates Essential Mitochondrial Function and Glucose Metabolism (A) Knockdown efficiency of two TIN2 shRNAs in HTC75 cells. (B) Total cellular ATP (base) and oligomycin-resistant ATP content were determined using cells from (A). (C) Quantification of mitochondrial membrane potential (MMP) of cells from (A). (D) Quantification of oxygen consumption in intact cells (base) and following oligomycin treatment. (E) Growth analysis of cells from (A) in glucose-containing DMEM media. (F) Measurement of media lactate levels of cells from (A). (G) Schematic representation of glycolysis. (H) Mass spectrometry analysis of glycolytic metabolites in HT1080 cells expressing control shRNA, TIN2 shRNA alone or with RNAi-resistant wild-type TIN2. Relative levels of the underlined metabolites from (G) were plotted. (I) TIN2 knockdown MCF-7 cells were cultured under normoxia (21% O2) or hypoxia (1% O2) conditions and western blotted. (J) HT1080 cells expressing TIN2 shRNA alone, or with RNAi-resistant wild-type or mutant TIN2 proteins were assessed under normoxia versus hypoxia conditions. (K) Measurement of reactive oxygen species (ROS) in TIN2 knockdown cells. (L) Measurement of ROS in HT1080 cells expressing TIN2 shRNA alone or together with untagged RNAi-resistant wild-type or mutant TIN2. For all panels, error bars represent SE (n = 3). P values were calculated using Student’s t test (∗p < 0.05; ∗∗p < 0.01). See also Figure S2. Molecular Cell 2012 47, 839-850DOI: (10.1016/j.molcel.2012.07.002) Copyright © 2012 Elsevier Inc. Terms and Conditions